GE HealthCare Technologies Inc. which can be found using ticker (GEHC) have now 10 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The range between the high target price and low target price is between $99.00 and $78.00 calculating the mean target price we have $88.00. Now with the previous closing price of $63.17 and the analysts are correct then there would likely be a percentage uptick in value of 39.3%. It’s also worth noting that there is a 50 day moving average of $66.81 and the 200 moving average now moves to $74.31. The company has a market cap of 30.72B. The stock price for the company is currently $67.54 USD
The potential market cap would be $42,791,496,995 based on the market consensus.
The company has a dividend yield of 0.77%. Other points of data to note are a P/E ratio of 18.71, revenue per share of $41.86 and a 5.77% return on assets.
GE HealthCare Technologies Inc. is a global medical technology, pharmaceutical diagnostics, and digital solutions company. The Company develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. The Company’s segments include Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics. The Imaging segment includes scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment includes screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment includes medical devices, services, consumable products, services, and digital solutions. The Pharmaceutical Diagnostics segment is a supplier of diagnostic agents to the global radiology and nuclear medicine industry.
